Pathogenesis of Hematologic Malignancies

Enrolling by invitationOBSERVATIONAL

Enrollment

5,000

Participants

Timeline

Start Date

September 30, 2008

Conditions

Acute LeukemiaLymphoproliferative DisordersMyeloproliferative DisordersMyelodysplastic Syndromes

Interventions

PROCEDURE

blood draw, bone marrow procedure, or tissue biopsy

Trial Locations (1)

OHSU Knight Cancer Institute, Portland

All Listed Sponsors

collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Cancer Institute (NCI)

NIH

lead

OHSU Knight Cancer Institute

OTHER

NCT01728402 - Pathogenesis of Hematologic Malignancies | Biotech Hunter | Biotech Hunter